Oxford Cannabinoid Technologies

About:

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

Website: https://www.oxcantech.com/

Twitter/X: OxCanTech

Top Investors: Casa Verde Capital, Julien Codorniou, Neil Mahapatra, Kingsley Capital Partners, Cantheon Capital

Description:

Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.